A Rare Case of Extraosseous Ewing Sarcoma Primarily Arising in the Ovary
Hou Min-min,Xi Ming-rong,Yang Kai-xuan
DOI: https://doi.org/10.3760/cma.j.issn.0366-6999.20131000
IF: 6.133
2013-01-01
Chinese Medical Journal
Abstract:To the editor: An 18-year-old woman, G0P0, presented with a 1-month history of abdominal distention. She had 2-year of sexual history. She had regular menstrual cycles and was not using drugs. No other significant history was noted. Clinically, her general condition was dissatisfactory, with anemic face, weight-loss. Systemic examination was normal. Pelvic examination revealed a mass of 9 cm×10 cm ×10 cm on the right adnexa and a mass of 8 cm×6 cm ×6 cm on the lift adnexa. A Pap smear taken was normal. Computerized tomography (CT) of the chest was normal, but of the pelvic cavity showed there was mixed masses of bilateral adnexa and predominant ascites. Initial laboratory test showed she was fall in anemia (hemoglobin 63 g/L) and hypoproteinemia. CA125 value was 196 U/ml and CA199 value was 45 U/ml. The preliminary diagnosis was ovarian genital-cell tumor. After improving the general situation of the patient, explorative laparotomy was performed. There was about 4000 ml of ascites. The uterus was normal. Both ovaries have a mass, with size of 5 cm3 in the left and 9 cm3 in the right. The bilateral tubes were normal. The omentum was contractive to be a mass. An infiltrated focus with about 6 cm length was on the intestine. Lesions were scattered on throughout the peritoneum of pelvic cavity, mesentery, and Douglas' pouch. Frozen-section examination showed the lesion was malignant tumor, and was suspected to be malignant small cell tumor (pPNET). We performed cytoreduction and resected masses of bilateral ovaries, omentum and infiltrated intestine with anastomosis. The cytoreduction was satisfied. All samples were sent for histopathological examination. No significant surgical or medical complication occurred and the patient was discharged uneventfully. Microscopically, the tumors were composed of monotonously uniform, small, round or oval cells with deeply stained nuclei and thin cytoplasm. Nuclear division was seen in Figure 1A. Immunohistochemically, there was strong membrane staining for CD99 (Figure 1B) and strong nucleus staining for FLI-1(Figure 1C). Fluorescence in situ hybridization (FISH) analysis showed EWS rearrangement-positive tumor cells composed >10% of all cells in each microscopic field (Figure 1D). Combination of histological, immunohistochemical, and molecular cytogenetic features, the patient was finally diagnosed with ovarian extraosseous ewing's sarcoma (EES), stage IIIc.Figure 1. A: : The tumor was small, round or oval with a consistent size (HE, original magnification ×200); B: Ewing's sarcoma cells express CD99 protein (EnVision, original magnification×200); C: Ewing's sarcoma cells express FLI-1 protein (EnVision, original magnification×200); D: EWS rearrangement-positive tumor cells show one fusion, one orange, and one green signal pattern (arrows show EWS rearrangement signals, FISH, original magnification ×1000).After recovery from operation, we formulated chemotherapy of IAD (Ifosfamide 1.5 g/m2 d1-d3; Epirubicin 25 mg/m2, d1-d3; Dacarbazine 300 mg/m2 d1-d3) regimen of 6 cycles for the patient and the disease was complete release. While 10 months later, the patient presented with recurrence. Although we gave IAD regimen chemotherapy once again, the girl eventually died. In this study, a tumor of the ovaries with the clinical characteristics of ovarian cancer was shown to be an EES by pathological, immunohistochemical and molecular genetic data. It cannot be expected before operation. During the operation, result of the frozen section suspected that the tumor was pPNET, and the final pathology showed it was EES. EES and pPNET both are small round cell tumors with varying degree of neuroectodermal differentiation. In recent years, cytogenetic studies have shown that pPNET, EES, Askin tumor and neuroepithelioma all shared a specific translocation involving the EWS gene on 22q12. As such, these tumors are now regarded as a single entity, collectively known as Ewing's sarcoma family of tumors (ESFT). EES was rare, and frequently involves the chest wall, paravertebral area, or lower extremity preponderance of children and young adults. Most ovarian malignancies present with pelvic mass and ascites at initial diagnose. Our case was not an exception. The treatment strategy for ovarian cancer is comprehensive, including surgical procedure, adjunctive chemotherapy and others. The pelvic EES has characteristics of highly-aggressive and frequently metastasis to bone. As a member of ESFT, the treatment strategies for EES were comprehensive treatment, including surgery, multi-drug combination chemotherapy, and radiotherapy. However, the overall survival rate is unsatisfactory, and the prognostic factors include tumor size, tumor location, stage of disease, or radiation therapy. Knowledge about EES of ovary is rare and there is no definitive treatment protocol. Based on the final pathology, we selected chemotherapy with IAD regimen for our patient. In spite of intensive treatment, the malignancy is still hard to be controlled. In conclusion, EES is a kind of tumors with characteristics of highlyaggressive and poor patient outcome. This report describes a case of EES primarily arising from ovary, which because of its rarity, is not have been suspected preoperatively. A timely and accurate diagnose can be achieved by the combination of immunohistochemical and molecular cytogenetic studies. And an accurate diagnose is paramount essential for selecting appropriate treatment options and assessing prognostic stratification for the patient.